Published: Thu, May 25, 2017
Money | By Armando Alvarado

Jazz Pharmaceuticals plc - (JAZZ) Shares Sold by Tredje AP fonden


Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) has risen 1.25% since May 24, 2016 and is uptrending. The original version of this news story can be accessed at https://transcriptdaily.com/2017/05/24/bancorpsouth-inc-acquires-734-shares-of-jazz-pharmaceuticals-plc-jazz.html. The specialty pharmaceutical company reported $1.41 earnings per share for the quarter, missing analysts' consensus estimates of $1.42 by $0.01. Howe Rusling has invested 0.01% of its portfolio in Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ). It has underperformed by 15.45% the S&P500. Credit Suisse Ag reported 110,454 shares stake. HBK Sorce Advisory LLC now owns 2,344 shares of the specialty pharmaceutical company's stock worth $285,000 after buying an additional 52 shares during the period. APG Asset Management N.V. now owns 264,635 shares of the specialty pharmaceutical company's stock valued at $32,148,000 after buying an additional 176,300 shares in the last quarter.

WARNING: "Jazz Pharmaceuticals plc - (JAZZ) Downgraded by Zacks Investment Research to Sell" was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. The stock declined 0.39% or $0.58 reaching $150.03 on the news. 246,631 shares of the company's stock traded hands. Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) has risen 1.25% since May 24, 2016 and is uptrending.

Since January 1, 0001, it had 0 buys, and 1 sale for $492,676 activity. Westlake Lisa sold 730 shares worth $69,357. The company was maintained on Tuesday, February 21 by Mizuho. Another trade for 61,667 shares valued at $6.99 million was sold by MCDANIEL RAYMOND W. Another trade for 1,499 shares valued at $168,033 was sold by Crimmins Michael S.

Investors sentiment decreased to 0.68 in Q4 2016. Its down 0.13, from 0.81 in 2016Q3.

Several hedge funds and other institutional investors have recently bought and sold shares of JAZZ. 63 funds opened positions while 149 raised stakes. 237.57 million shares or 1.21% less from 240.49 million shares in 2016Q3 were reported. Green Square Limited Co reported 8,270 shares. Capital Management Associates Ny owns 10,730 shares or 1.96% of their United States portfolio. Cornerstone Advisors Inc invested in 10,600 shares. Public Employees Retirement Association Of Colorado owns 35,379 shares. Parallax Volatility Advisers L P, California-based fund reported 12,500 shares. Kbc Group Inc Nv holds 128,615 shares. Tradewinds Capital Limited Liability Company has 75 shares. Princeton Alpha Mngmt Ltd Partnership invested in 5,305 shares or 0.12% of the stock. Henderson Gru Pcl invested in 22,748 shares. Capital Impact Advsrs Ltd Liability Co holds 5,726 shares or 0.26% of its portfolio.

Vgi Partners Pty Ltd holds 6.05% of its portfolio in WD-40 Company for 205,226 shares. Finally, Mizuho reissued a "buy" rating and set a $152.00 target price on shares of Jazz Pharmaceuticals plc - in a research report on Wednesday, March 1st. Therefore 11% are positive. Jazz Pharmaceuticals had 11 analyst reports since February 21, 2017 according to SRatingsIntel. The rating was downgraded by Barclays Capital on Tuesday, January 10 to "Equal Weight". Corporate insiders own 3.90% of the company's stock. The firm has "Outperform" rating given on Thursday, May 11 by Cowen & Co. Mizuho maintained Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) on Tuesday, February 21 with "Buy" rating. Wedbush initiated the stock with "Neutral" rating in Friday, September 9 report. During the same quarter in the previous year, the firm posted $2.26 earnings per share. The rating was maintained by Wunderlich with "Hold" on Thursday, October 20. On Friday, April 15 the stock rating was initiated by Compass Point with "Sell". Following the completion of the transaction, the executive vice president now owns 22,623 shares of the company's stock, valued at approximately $3,460,866.54. Jazz has also had its share of pipeline setbacks. Energy Select Sector Spdr (XLE) was reduced too.

Calgary artist touring in Manchester expresses heartbreak in wake of terror attack
Mayor Eddy Newman and the city's police chief spoke to the crowd and held a moment of silence to remember those that died. Flowers laid beneath Cobden statue in St Ann's Square in Manchester to mourn victims of the bomb attack.

Since November 15, 2016, it had 0 buys, and 9 sales for $2.94 million activity. The insider ENRIGHT PATRICK G sold $68,919. Another trade for 11,458 shares valued at $1.74 million was made by WILSON KAREN J on Monday, April 10.

In other news, EVP Michael Patrick Miller sold 200 shares of Jazz Pharmaceuticals plc - stock in a transaction dated Monday, May 15th. $515,000 worth of Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) was sold by Cox Russell J. on Wednesday, January 18. $400,000 worth of stock was sold by Hooper Suzanne Sawochka on Tuesday, May 9. The insider Cox Russell J. sold $515,000. Treacy Paul sold 884 shares worth $116,666.

Investors sentiment decreased to 0.68 in 2016 Q4. Its down 0.08, from 1.06 in 2016Q3. It fall, as 64 investors sold Jazz Pharmaceuticals plc - Ordinary Shares shares while 111 reduced holdings. Envestnet Asset Management Inc. increased its stake in shares of Jazz Pharmaceuticals plc - by 43.0% in the first quarter. Its up 40.74% from 29,700 shares previously.

Jazz Pharmaceuticals plc - (NASDAQ:JAZZ) traded down 0.89% on Tuesday, hitting $150.61. Maryland-based Brown Mngmt Ltd Company has invested 0.01% in Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ). Moreover, Blackrock Institutional Communications Na has 0.02% invested in Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) for 1.09 million shares. 52,291 were reported by Stevens Cap Mgmt Limited Partnership. Tealwood Asset Mgmt owns 20,072 shares. Charter Tru holds 16,539 shares. Westpac holds 0% of its portfolio in Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) for 13,603 shares. Da Davidson & accumulated 100 shares.

Cadian Capital Management Lp, which manages about $5.56B and $1.88 billion US Long portfolio, decreased its stake in Pros Holdings Inc (NYSE:PRO) by 601,500 shares to 1.54M shares, valued at $33.14M in 2016Q4, according to the filing. Pioneer Investment reported 822,687 shares stake. Janney Montgomery Scott upgraded shares of Jazz Pharmaceuticals plc - from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $138.00 to $175.00 in a report on Thursday, April 6th. Rock Springs Capital Management LP now owns 107,000 shares of the specialty pharmaceutical company's stock worth $12,998,000 after buying an additional 5,000 shares during the period.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this: